FDA Approves Ultrasound Device to Treat Essential Tremor

Share this content:
FDA Approves Ultrasound Device to Treat Essential Tremor
FDA Approves Ultrasound Device to Treat Essential Tremor

MONDAY, July 11, 2016 (HealthDay News) -- The ExAblate Neuro device has been approved by the U.S. Food and Drug Administration to deliver focused ultrasound to destroy tissue in a tiny area of the brain that is thought to be involved in essential tremor.

The device, approved for patients who haven't responded to medication or surgery, uses magnetic resonance imaging (MRI) to help doctors focus ultrasound on specific areas of the brain, the FDA explained Monday in a news release. Patients are awake and responsive during the entire procedure, the agency added.

The device was evaluated in a clinical study involving 76 participants. Those who used the ExAblate device showed nearly a 50 percent improvement in essential tremor, compared to those who used a sham device. Side effects of the ExAblate device included finger numbness, headache, unsteadiness, ataxia, and gait disturbance. Additional potential side effects included skin burns, scar formation, and blood clots, the FDA said.

The device shouldn't be used by patients who cannot have an MRI, including those who have had implantation of a metallic medical device such as a pacemaker, the agency said. Pregnant women and patients with advanced kidney disease, unstable heart conditions, or hypertension also shouldn't have the procedure.

The ExAblate Neuro device is produced by InSightec, based in Dallas.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Cognitive Training Can Positively Affect Perception of Tinnitus

Cognitive Training Can Positively Affect Perception of Tinnitus

Researchers find computer-based program allows patients to cope better with tinnitus

Early Study Results Promising for Genital Herpes Vaccine

Early Study Results Promising for Genital Herpes Vaccine

Two-pronged approach tested on lab monkeys, guinea pigs

Type 1 Diabetes Tied to Gut Inflammation, Microbiota

Type 1 Diabetes Tied to Gut Inflammation, Microbiota

Type 1 diabetes patients exhibit different and distinct inflammation and gut microbiota

is free, fast, and customized just for you!

Already a member?

Sign In Now »